immunodefici
mice
engraft
human
peripher
blood
cell
promis
tool
vivo
analysi
human
patient
individu
immun
respons
howev
human
peripher
blood
mononuclear
cell
pbmc
transfer
nog
nodshiscid
null
mice
sever
graft
versu
host
diseas
gvhd
hinder
long
term
detail
analysi
administr
human
pbmc
newli
develop
murin
mhc
class
iand
class
iidefici
nog
nogdko
nogiab
mice
show
suffici
engraft
human
immun
cell
littl
sign
gvhd
immun
influenza
vaccin
result
increas
influenzaspecif
human
igg
ab
indic
induct
antigenspecif
b
cell
nogdko
mice
immun
human
dendrit
cell
puls
restrict
cytomegaloviru
peptid
induc
specif
cytotox
cell
indic
induct
antigenspecif
cell
nogdko
mice
adopt
cell
therapi
act
use
melanoma
antigen
recogn
cell
specif
tcrtransduc
activ
cell
show
strong
tumor
growth
inhibit
nogdko
mice
without
sign
gvhd
accompani
preferenti
expans
transfer
cell
act
use
cultur
human
melanoma
infiltr
cell
also
show
antitumor
effect
autolog
melanoma
cell
nogdko
mice
chang
human
cancer
phenotyp
immun
intervent
increas
express
could
evalu
therefor
nogdko
mice
use
tool
detail
analysi
induct
effector
phase
tcell
bcell
respons
longer
period
regular
nog
mice
human
vivo
immun
respons
often
presum
mous
model
vivo
studi
human
biolog
limit
ethic
technic
problem
howev
signific
differ
human
mice
tcell
bcell
signal
pathway
compon
differenti
tolllik
receptor
cytokin
receptor
overcom
problem
variou
human
mice
human
immun
system
studi
vivo
recent
develop
commonli
use
human
mous
model
immunodefici
null
mous
strain
nog
nodshiprkdc
scid
jic
mice
nsg
nodltszprkdc
scid
j
mice
engraft
human
tissu
human
hematopoiet
cell
hsc
human
peripher
blood
mononuclear
cell
pbmc
human
immun
cell
analyz
convent
human
hscengraft
nognsg
mice
human
multilineag
hematopoiet
cell
includ
lymphoid
cell
myeloid
cell
develop
transplant
human
hsc
mice
wide
use
human
immunolog
research
howev
human
mice
still
insuffici
develop
human
cell
fulli
function
exampl
although
immun
human
mice
antigen
lead
product
antigenspecif
igm
antigenspecif
igg
respons
weak
tcell
differenti
gener
singleposit
cell
seem
rel
normal
human
mice
howev
function
cell
especi
induct
antigenspecif
tcell
respons
remain
controversi
one
reason
thought
mismatch
mous
mhc
hla
donor
human
hsc
overcom
issu
new
immunodefici
null
mous
strain
express
human
hla
class
class
ii
molecul
gener
show
hlarestrict
antigenspecif
ctl
respons
antigenspecif
igg
respons
although
hscengraft
human
mice
improv
understand
vivo
human
immun
cell
develop
function
mice
could
reconstruct
current
immun
statu
human
individu
includ
patient
human
hematopoiet
cell
reconstitut
hsc
particular
analyz
associ
cell
autolog
tissu
includ
cancer
cell
hscengraft
human
mice
nearli
imposs
difficult
obtain
hsc
tissu
patient
human
pbmcengraft
human
mice
attract
model
vivo
analysi
individu
human
patient
immun
respons
previous
report
human
pbmc
could
engraft
nog
mice
much
better
immunodefici
mice
howev
sever
xenogen
graft
versu
host
diseas
xenogvhd
mice
limit
window
experiment
engraft
cell
activ
xenogvhd
mice
die
xenogvhd
make
difficult
analyz
human
immun
respons
precis
previous
murin
class
mhc
class
ii
mhcknockout
nsg
mice
develop
analyz
xenogvhd
phenotyp
immun
respons
transfer
human
pbmc
clearli
evalu
yet
studi
overcom
xenogvhd
problem
use
human
pbmcengraft
human
mice
confound
induc
human
immun
respons
develop
murin
mhc
class
iand
class
iidefici
nog
mice
analyz
whether
mice
engraft
human
pbmc
could
use
tool
analysi
induct
effector
phase
human
tcell
bcell
respons
mice
nodcgprkdc
scid
jic
nodscid
null
nog
nodcgprkdc
scid
jic
nogiab
null
null
nogdko
mice
use
studi
nog
mice
establish
previous
report
nogdko
mice
establish
follow
iab
null
nodcgprkdc
scid
szj
nodscid
null
mice
kind
gift
dr
mathi
harvard
medic
school
dr
shultz
l
jackson
laboratori
bar
harbor
usa
respect
iab
null
mice
first
backcross
mice
seven
gener
establish
null
mice
backcross
nog
mice
speed
congen
techniqu
combin
markerassist
select
protocol
vitro
fertil
obtain
nogiab
null
mice
null
mice
also
establish
backcrossm
nodscid
null
nog
mice
introduc
gene
nogdko
mice
obtain
mate
nogiab
null
null
mice
genotyp
null
mice
nogiab
null
mice
differ
primer
use
detect
wt
ko
genotyp
primer
use
detect
microglobulin
gene
iab
gene
follow
gene
pi
forward
pii
revers
wt
piii
revers
mu
iab
gene
pi
iab
forward
pii
iab
revers
wt
piii
iab
revers
mu
genom
dna
extract
tail
mice
pcr
reaction
condit
follow
cycl
min
band
detect
mutant
pi
piii
primer
pair
band
detect
wildtyp
pi
pii
primer
pair
band
detect
mutant
iab
pi
piii
primer
pair
band
detect
wildtyp
iab
pi
pii
primer
pair
absenc
mhc
class
molecul
express
nog
strain
b
surfac
cell
nogdko
mice
confirm
fac
supplementari
figur
mous
care
experiment
procedur
perform
pathogenfre
condit
accord
establish
guidelin
keio
univers
central
institut
experiment
anim
gener
human
pbmctransplant
mice
human
pbmc
collect
healthi
volunt
inform
consent
use
lymphoprep
axisshield
poc
oslo
norway
inject
mice
intraven
mous
human
melanoma
cell
line
cell
express
transfect
genom
clone
obtain
surgeri
branch
nation
cancer
institut
nation
institut
health
bethesda
md
melanoma
cell
line
establish
patient
cell
establish
previous
describ
cell
cultur
invitrogen
carlsbad
ca
usa
supplement
fetal
bovin
serum
antibiot
cell
cultur
maintain
co
incub
peripher
blood
cell
hpbmcnog
mice
stain
fluoresceinconjug
monoclon
antibodi
ab
h
red
blood
cell
lyse
use
optilys
c
beckman
coulter
inc
brea
ca
usa
stain
cell
analyz
use
gallio
beckman
coulter
inc
antibodi
use
studi
follow
alexa
flour
antihuman
pe
antihuman
tissu
sampl
fix
neutral
buffer
formalin
embed
paraffin
deparaffin
section
incub
hydrogen
peroxid
min
room
temperatur
pretreat
histovton
nacalai
tesqu
kyoto
japan
min
block
goat
serum
specimen
incub
antihuman
ab
dako
japan
tokyo
japan
overnight
avidinbiotin
complex
method
perform
vectastain
abc
human
igg
kit
vector
laboratori
burlingam
ca
usa
accord
manufactur
instruct
section
develop
dab
hydrogen
peroxid
muto
pure
chemic
tokyo
japan
counterstain
hematoxylin
determin
number
cell
five
field
magnif
per
specimen
randomli
chosen
posit
count
averag
influenza
hemagglutinin
ha
vaccin
season
kitasato
institut
saitama
japan
clinic
use
human
obtain
hospit
pharmaci
briefli
ha
intraperiton
administ
one
day
human
pbmc
transplant
day
antiha
igg
titer
sera
mice
measur
day
day
elisa
day
antiha
iggproduc
b
cell
examin
enzymelink
immunospot
assay
elispot
total
human
igg
mous
sera
measur
human
igg
elisa
kit
abcam
cambridg
uk
accord
manufactur
instruct
rel
concentr
antiha
antibodi
mous
sera
measur
elisa
influenza
ha
vaccin
season
kitasato
institut
saitama
japan
dilut
pb
ml
coat
microimmun
plate
nunc
denmark
per
well
h
room
temperatur
three
wash
pb
plate
block
fbspb
per
well
h
room
temperatur
sampl
sera
dilut
threefold
serial
dilut
fbspb
block
plate
wash
pbst
three
time
serial
dilut
sampl
sera
standard
serum
per
well
incub
h
room
temperatur
three
wash
pbst
sampl
incub
horseradish
peroxidas
hrp
conjug
goat
antihuman
igg
southern
biotechnolog
associ
birmingham
al
usa
fbspb
per
well
h
room
temperatur
hrp
activ
visual
use
tetramethyl
benzidinefre
base
sigma
st
loui
mo
usa
phosphatecitr
buffer
rel
concentr
antiha
antibodi
estim
comparison
standard
curv
plate
serum
healthi
volunt
antiha
igg
use
standard
serum
titer
standard
sera
defin
uml
cell
remov
plate
wash
h
five
time
incub
mm
per
well
min
room
temperatur
plate
wash
pbst
three
time
pb
one
time
incub
bsapb
overnight
plate
overlaid
alkalin
phosphataselabel
antihuman
detect
antibodi
southern
biotech
birmingham
al
usa
h
room
temperatur
wash
pb
precipit
substrat
alkalin
phosphatas
ad
plate
incub
spot
emerg
site
respond
cell
spot
count
use
ctlimmunospot
micro
analyz
cellular
technolog
limit
shaker
height
oh
usa
variou
cytokin
sera
hpbmcnogdko
mice
hpbmcnog
mice
measur
day
human
pbmc
implant
use
bioplex
pro
human
cytokin
grp
panel
grp
panel
biorad
hercul
ca
usa
accord
manufactur
instruct
human
monocytederiv
dc
modc
gener
previous
report
briefli
human
monocyt
isol
human
pbmc
use
mac
bead
miltenyi
biotec
bergisch
gladbach
germani
cultur
dc
medium
contain
human
autolog
sera
gmcsf
ngml
ngml
day
cm
dish
ngml
ngml
ngml
uml
ngml
poli
c
mgml
ad
cell
matur
day
modc
harvest
puls
restrict
peptid
nlvpmvatv
ml
aimv
medium
h
puls
modc
intraven
administ
human
pbmctransfer
nogdko
mice
dc
vaccin
administ
day
day
day
unpuls
modc
administ
control
group
day
human
cell
harvest
spleen
peripher
blood
bone
marrow
vaccinatednogdko
mice
use
mac
bead
miltenyi
biotec
sort
human
cell
per
well
per
ml
cocultur
irradi
gy
celldeplet
autolog
pbmc
per
well
per
ml
plate
peptid
u
ml
ngml
day
cell
harvest
use
lymphoprep
axisshield
poc
stain
brilliant
violet
pe
hlaa
cmv
tetramernlvpmvatv
mbl
nagoya
japan
pe
hlaa
hiv
gag
tetramerslyntvatl
mbl
use
neg
control
gener
cell
cell
martt
gener
previous
describ
briefli
plasmid
encod
hlaa
tcr
gift
dr
kenichi
hanada
surgeri
branch
nation
cancer
institut
nation
institut
health
usa
pbmc
healthi
donor
stimul
solubl
ngml
recombin
human
iuml
novarti
east
hanov
nj
usa
day
transduct
stimul
cell
transfect
retroviru
express
tcr
gene
specif
gener
martt
evalu
determin
product
martt
cocultur
epitop
peptid
ktwgqywqv
elagigiltv
puls
cell
vitro
expans
human
melanoma
til
cell
cultur
tumor
infiltr
lymphocyt
establish
patient
cell
establish
describ
previous
briefli
melanoma
tumor
digest
cultur
plate
contain
ml
supplement
human
serum
antibiot
recombin
human
iuml
novarti
five
day
initi
half
medium
replac
fresh
complet
medium
contain
repeat
everi
day
thereaft
need
recognit
cell
cell
confirm
examin
product
cell
cocultur
cell
antihlaabc
ab
bioxcel
west
lebanon
nh
usa
mous
isotyp
control
bioxcel
adopt
cancer
immunotherapi
model
briefli
cell
subcutan
inocul
flank
nog
nogdko
mice
cultur
martt
cell
per
mous
intraven
administ
day
cell
subcutan
inocul
flank
nogdko
mice
cultur
cell
intraperiton
administ
day
day
tumor
volum
calcul
accord
follow
formula
length
width
mild
gvhd
human
pbmctransplant
murin
mhc
class
iand
class
iidefici
nog
mice
murin
mhc
class
iand
class
iidefici
nog
nodshiscid
null
mice
nogdko
gener
mate
nog
mice
null
iabknockout
nog
mice
nogiab
null
verifi
use
nogdko
mice
mous
model
enabl
longterm
analysi
immun
respons
transplant
human
peripher
immun
cell
compar
onset
symptom
xenogvhd
nog
mice
nogdko
mice
human
pbmc
transplant
nog
mice
implant
human
pbmc
hpbmcnog
die
sever
xenogvhd
within
week
reduct
bodi
weight
figur
human
tcell
infiltr
variou
organ
includ
kidney
liver
colon
skin
lung
spleen
nogdko
mice
implant
human
pbmc
hpbmcnogdko
surviv
month
without
signific
bodi
weight
loss
less
human
tcell
infiltr
variou
organ
figur
b
supplementari
figur
also
measur
variou
human
cytokin
mous
sera
day
use
bioplex
found
nogdko
pgml
nog
pgml
ttest
rant
nogdko
pgml
nog
pgml
ttest
known
relat
tcell
activ
significantli
lower
sera
nogdko
mice
result
suggest
nogdko
mous
might
use
mous
model
analyz
transfer
human
pbmc
less
xenogvhd
effect
engraft
transfer
human
pbmc
nogdko
mice
cell
cell
major
popul
transfer
human
pbmc
expand
nog
mice
nogdko
mice
figur
b
transfer
human
cell
increas
moder
nogdko
mice
nog
mice
could
detect
least
month
figur
figur
although
number
b
cell
peripher
blood
rel
low
detect
least
month
figur
human
igg
also
detect
sera
day
ml
day
compar
spleen
peripher
blood
bone
marrow
contain
much
higher
number
b
cell
memori
bcell
phenotyp
day
suggest
possibl
memori
b
cell
home
bone
marrow
figur
cell
b
cell
detect
least
month
nogdko
mice
dendrit
cell
hladr
cell
detect
day
figur
result
indic
human
b
cell
cell
antigen
present
cell
engraft
nogdko
mice
littl
sign
gvhd
number
indic
cell
nog
mice
significantli
higher
nogdko
mice
day
mark
b
b
number
indic
cell
significantli
lower
c
ttest
appli
logarithm
scale
b
linear
scale
c
next
evalu
whether
antigenspecif
bcell
respons
induc
hpbmcnogdko
mice
human
pbmc
transfer
nogdko
mice
healthi
human
volunt
antiinfluenza
hemagglutinin
ha
igg
antibodi
sera
mice
intraperiton
immun
ha
vaccin
day
vaccin
increas
human
haspecif
igg
ab
figur
haspecif
igg
product
transfer
human
b
cell
figur
observ
sera
spleen
nogdko
mice
respect
result
suggest
antigenspecif
bcell
respons
induc
immun
antigen
hpbmcnogdko
mice
induct
antigenspecif
tcell
respons
dendrit
cell
vaccin
human
pbmctransfer
nogdko
mice
next
evalu
whether
antigenspecif
tcell
respons
could
induc
hpbmcnogdko
mice
poor
surviv
antigen
present
cell
includ
dendrit
cell
hpbmcnogdko
mice
figur
repeatedli
immun
mice
antigenpuls
autolog
matur
monocytederiv
dendrit
cell
modc
induct
antigenspecif
cell
human
pbmc
healthi
volunt
memori
cmvspecif
cell
transfer
nogdko
mice
weakli
immun
mice
autolog
modc
puls
cmv
antigenderiv
peptid
nlvpmvatv
three
time
dc
immun
human
cell
isol
spleen
peripher
blood
bone
marrow
immun
hpbmcnogdko
mice
restimul
peptid
week
vitro
evalu
induct
cell
use
tetram
figur
tcell
induct
observ
spleen
bone
marrow
peripher
blood
dcimmun
mice
figur
indic
induct
antigenspecif
cell
evalu
hpbmcnogdko
mice
adopt
transfer
tumorspecif
cell
show
antitumor
effect
littl
sign
gvhd
nogdko
mice
nog
mice
use
previous
evalu
vivo
kill
activ
adopt
transfer
human
tumorspecif
cell
howev
sever
gvhd
obstacl
longterm
followup
precis
evalu
function
cell
evalu
whether
nogdko
mice
use
mous
model
tcellbas
adopt
cancer
immunotherapi
implant
mel
human
melanoma
cell
line
express
human
melanoma
antigen
nog
mice
nogdko
mice
treat
cell
martt
gener
transduc
tcr
gene
activ
pbmcderiv
cell
healthi
human
volunt
figur
nogdko
mice
show
antitumor
effect
induc
martt
administr
bodi
weight
loss
figur
c
coadministr
exogen
human
recombin
prolong
surviv
cell
higher
tetramerposit
cell
enhanc
antitumor
effect
nogdko
mice
figur
e
although
nog
mice
show
stronger
antitumor
effect
along
increas
transfer
cell
probabl
due
strong
tcell
expans
via
xenogen
gvhd
respons
ratio
cell
cell
smaller
nogdko
mice
suggest
tcell
phenotyp
modifi
xenogen
gvhd
respons
nog
mice
figur
next
treat
human
melanomabear
nogdko
mice
autolog
tumor
infiltr
lymphocyt
til
nogdko
mice
administr
cultur
tumor
infiltr
cell
cell
figur
show
signific
antitumor
effect
autolog
melanoma
cell
line
establish
patient
cell
establish
figur
human
melanoma
cell
report
induc
involv
suppress
melanomaspecif
ctl
found
increas
melanoma
cell
figur
suggest
nogdko
mice
might
also
use
evalu
chang
human
cancer
phenotyp
induc
tcell
follow
immun
intervent
altogeth
result
studi
demonstr
nogdko
mice
use
detail
longterm
analysi
bcell
respons
cell
respons
induct
effector
phase
human
peripher
blood
regular
nog
mice
human
pbmcengraft
immunodefici
mice
might
good
model
analyz
human
individu
immun
statu
bcell
respons
vaccin
tcell
respons
autolog
cancer
howev
sever
xenogvhd
formid
obstacl
long
term
precis
evalu
human
immun
respons
induc
mice
gener
nognsg
mice
addit
lack
nk
activ
show
signific
improv
surviv
engraft
human
pbmc
xenogvhd
induct
compar
immunodefici
mous
model
nodscid
mice
king
et
al
report
develop
xenogvhd
nsg
mice
highli
depend
host
express
murin
mhc
class
class
ii
molecul
shown
mhc
class
isingleknockout
mice
mhc
class
iisingleknockout
mice
develop
xenogvhd
studi
doubleknockout
murin
mhc
class
class
ii
molecul
result
much
milder
xenogvhd
hpbmcnogdko
mice
suggest
togeth
mhc
class
mhc
class
ii
molecul
recipi
play
major
role
pathogenesi
gvhd
although
obviou
symptomat
sign
gvhd
hpbmcnogdko
mice
number
human
cell
hpbmcnogdko
mice
continu
increas
three
week
pbmc
engraft
mild
human
tcell
infiltr
observ
organ
figur
supplementari
figur
one
possibl
mechan
incomplet
downregul
mhc
class
molecul
delet
microglobulin
gene
although
confirm
littl
express
mhc
class
molecul
surfac
cell
nogdko
mice
supplementari
figur
possibl
mechan
involv
stimul
engraft
human
cell
might
homeostat
prolifer
engraft
human
antigenpres
cell
present
murin
protein
murin
minor
histocompat
antigen
mha
analysi
need
elucid
mechan
underli
tcell
stimulatori
effect
bcell
respons
human
pbmcengraft
immunodefici
mice
previous
report
exampl
okada
et
al
report
vaccin
cdna
construct
encod
antigen
protein
sever
acut
respiratori
corona
viru
induc
product
agspecif
antibodi
howev
bcell
respons
mice
might
influenc
xenogvhd
reaction
studi
show
influenza
haspecif
igg
product
hpbmcnogdko
mice
vaccin
ha
antigen
suggest
even
littl
inflamm
caus
xenogvhd
reaction
bcell
respons
induc
lack
xenogvhd
mous
model
enabl
longterm
precis
evalu
human
bcell
characterist
respons
exampl
observ
b
cell
home
bone
marrow
bm
almost
month
longterm
human
pbmc
transfer
nogdko
mice
figur
interest
mechan
human
bcell
home
bm
gener
memori
b
cell
could
analyz
use
mous
model
consid
lack
de
novo
multilineag
human
hematopoiesi
seem
difficult
induc
primari
immun
respons
human
pbmcengraft
immunodefici
mous
model
thu
mechan
igg
product
mous
model
might
relat
reactiv
antigenexperienc
memori
b
cell
whether
primari
immun
respons
induc
suppli
antigen
present
cell
mous
model
remain
evalu
futur
although
develop
cell
reconstitut
human
acquir
immun
shown
human
hsctransplant
immunodefici
null
mous
strain
induct
human
hlarestrict
tcell
respons
human
mice
limit
lack
hla
express
group
report
introduct
human
hla
express
improv
human
hlarestrict
ctl
respons
previou
studi
use
human
hsc
reconstitut
human
immun
system
suitabl
analyz
human
current
immun
statu
individu
includ
patient
chun
et
al
previous
report
nodscid
microglobulin
mice
engraft
human
hsc
reconstitut
autolog
peripher
cell
could
induc
hlarestrict
tcell
respons
influenza
viru
vaccin
spranger
et
al
previous
report
humanpbmc
engraft
nsg
mice
vaccin
human
modc
express
could
induc
cell
previou
studi
show
induct
hlarestrict
tcell
respons
human
peripher
blood
howev
influenc
xenogvhd
might
problem
evalu
tcell
respons
human
mice
studi
show
immun
human
modc
puls
restrict
cmv
peptid
induc
cmvspecif
ctl
hpbmcnogdko
mice
human
mous
system
show
littl
xenogen
stimul
antigenspecif
cell
could
induc
system
may
attract
model
precis
evalu
human
peripher
tcell
respons
evalu
antitumor
effect
human
tumorspecif
cell
tumor
infiltr
lymphocyt
genet
engin
human
cell
express
chimer
antigen
receptor
car
tcr
previou
studi
often
util
human
tumorbear
immun
defici
mice
nog
nsg
nodscid
mice
model
xenogvhd
reaction
stimul
transfer
cell
alter
phenotyp
mask
real
antitumor
effect
actual
experi
transfer
cell
preferenti
expand
nogdko
mice
compar
nog
mice
figur
effector
phase
antitumor
immun
respons
antitumor
cell
recogn
kill
tumor
cell
evalu
precis
longer
period
nogdko
mous
model
nog
mous
model
lack
xenogvhd
particular
tcell
phenotyp
anergi
exhaust
might
effect
evalu
colleagu
recent
report
immunotherapi
target
could
precis
evalu
nogdko
mice
nog
mice
xenogvhd
reaction
induc
nonspecif
tcell
activ
accompani
express
nog
mice
hand
short
longev
antigen
present
cell
current
mous
model
may
suitabl
evalu
induct
phase
antitumor
immun
respons
dc
suppli
shown
figur
varieti
immun
cell
macrophag
mdsc
treg
nk
cell
play
import
role
cancer
microenviron
also
well
support
current
mous
model
support
cell
develop
variou
human
cytokineproduc
transgen
nog
strain
conclus
compar
nog
mice
hpbmcnogdko
mice
use
analyz
current
human
individu
immun
statu
provid
longterm
precis
evalu
human
tcell
bcell
respons
